Filtered Listing Testing

Macular Degeneration Research

Age-related macular degeneration is a leading cause of vision loss in Americas aged 60 and older. Guest speaker Gayatri S. Reilly, MD will answer questions and share all the facts you need to know about both wet and dry macular degeneration.

Feb 28, 2024
Alzheimer's Disease Research

A new study asks the question: what if we could reverse the damage caused by Alzheimer’s disease-related proteins like tau? Learn more.

Feb 13, 2024
BrightFocus Foundation

Newly released research portfolios highlight the 276 biomedical research projects funded by BrightFocus Foundation across 16 countries to defeat Alzheimer’s disease, macular degeneration, and glaucoma. 

Feb 2, 2024
Alzheimer's Disease Research

The anti-amyloid therapy will go off the market later this year.

Feb 2, 2024
National Glaucoma Research

In This Issue:

  • Current Research: Could Vision Lost to Glaucoma Be Restored? 
  • President’s Corner 
  • A BrightFocus Glaucoma Chat with Dr. Nazlee Zebardast 
  • First Look at Upcoming Research 
  • And more!
Jan 10, 2024
Alzheimer's Disease Research

In this Issue

  • President’s Corner
  • New Blood Test Detects Unique Biomarker for Alzheimer’s
  • Researcher Spotlight: Kevin Beier, PhD
  • Medications That Can Mimic Dementia
  • Help Fight Alzheimer’s Through a Donor Advised Fund
Jan 10, 2024
National Glaucoma Research

January is Glaucoma Awareness Month, and BrightFocus Foundation is pleased to announce the 2024 schedule of Glaucoma Chats, free, accessible and interactive audio podcast conversations with leading glaucoma specialists and eye care professionals.

Jan 5, 2024
Macular Degeneration Research

A BrightFocus-funded study identifies a new player that is critical to help prevent a buildup of waste in the eye that could lead to macular degeneration.

Dec 18, 2023
National Glaucoma Research

The U.S. Food and Drug Administration has approved a new treatment for glaucoma, iDose® TR (travoprost intracameral implant, 75 mcg). iDose TR is a first-of-its kind treatment that is designed to provide up to three years of 24/7, continuous drug therapy directly inside the eye, helping people with glaucoma take control over the elevated eye pressure associated with this vision disease.

Dec 15, 2023
National Glaucoma Research

Medical marijuana has been shown to lower eye pressure, a key factor in glaucoma. But is it safe to use?

Dec 4, 2023